Circulating levels of ANP and BNP are used as clinical biomarkers with important diagnostic and therapeutic implications in hypertension and congestive heart failure (Burnett et al., 1986; Ruskoaho, 2003; Puyó et al., 2005; Rubattu et al., 2019). The gene discussed is NPPA; the disease is hypertensive disorder.